Skip to main content

Biostage, Inc. (BSTG)

OTCMKTS: BSTG · IEX Real-Time Price · USD
3.00 -0.05 (-1.64%)
Oct 26, 2021 11:24 AM EDT - Market closed

Total Valuation

Biostage has a market cap or net worth of $29.55 million. The enterprise value is $29.18 million.

Market Cap29.55M
Enterprise Value29.18M

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Biostage has 9.44 million shares outstanding. The number of shares has increased by 9.25% in one year.

Shares Outstanding9.44M
Shares Change (YoY)+9.25%
Shares Change (QoQ)+0.50%
Owned by Insiders (%)58.74%
Owned by Institutions (%)0.19%

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
PB Ratio40.59
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is n/a, with a EV/FCF ratio of n/a.

EV / Earningsn/a
EV / Salesn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 2.31, with a Debt / Equity ratio of 0.18.

Current Ratio2.31
Quick Ratio1.58
Debt / Equity0.18
Debt / EBITDA-0.05
Debt / FCF-0.04

Financial Efficiency

Return on Equity (ROE)-277.20%
Return on Assets (ROA)-157.50%
Return on Capital (ROIC)-492.60%
Revenue Per Employeen/a
Profits Per Employee-$490,000
Employee Count6
Asset Turnovern/a
Inventory Turnovern/a


Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

The stock price has increased by +124.26% in the last 52 weeks. The beta is -0.16, so Biostage's price volatility has been lower than the market average.

Beta (1Y)-0.16
52-Week Price Change+124.26%
50-Day Moving Average3.33
200-Day Moving Average1.97
Average Volume (30 Days)2,076

Short Selling Information

Short Interest121,658
Short % of Shares Out1.29%
Short % of Float2.67%
Short Ratio (days to cover)3.35

Income Statement

Gross Profitn/a
Operating Income-4.08M
Net Income-2.94M
Earnings Per Share (EPS)-$0.32
Full Income Statement

Balance Sheet

The company has $501,000 in cash and $130,000 in debt, giving a net cash position of $371,000 or $0.04 per share.

Cash & Cash Equivalents501,000
Total Debt130,000
Net Cash371,000
Net Cash Per Share$0.04
Book Value728,000
Book Value Per Share0.08
Working Capital473,000
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$3.05 million and capital expenditures -$7,000, giving a free cash flow of -$3.06 million.

Operating Cash Flow-3.05M
Capital Expenditures-7,000
Free Cash Flow-3.06M
FCF Per Share-$0.32
Full Cash Flow Statement


Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Biostage does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-9.95%
FCF Yield-10.35%
Dividend Growth (YoY)n/a
Payout Ration/a

Stock Splits

The last stock split was on December 22, 2017. It was a reverse split with a ratio of 1:20.

Last Split DateDec 22, 2017
Split TypeReverse
Split Ratio1:20